TANG CAPITAL MANAGEMENT LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001232621

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth Tilt how tags are computed

Q3 2023 · 106 positions · Total reported value $708.68M · Top-10 concentration 39.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 15.2% · 5 new · 1 cut · 1 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -8.5% · vs SPY -10.6% · Prev Value $2.20B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.0% · vs SPY -5.2% · Latest Value $2.17B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2023 13F filing, TANG CAPITAL MANAGEMENT LLC disclosed 106 equity positions with a combined reported value of $708.68M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 39.3% of reported value. HoldingsHub classifies the profile as Small / Health Tilt.

The largest disclosed positions as of Q3 2023 were TARS ($38.04M), MIRM ($35.93M), ANAB ($35.03M). By sector, the heaviest allocations are Health Care 65.1%, Financials 1.9%.

Versus the prior quarter, TANG CAPITAL MANAGEMENT LLC opened 5 new positions, trimmed 1 and fully exited 1, a turnover rate of 15.2% of positions.

The largest new positions opened in Q3 2023 were TARS ($38.04M), MIRM ($35.93M), ANAB ($35.03M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • TARS TARSUS PHARMACEUTICALS INC · $38.04M
  • MIRM MIRUM PHARMACEUTICALS INC · $35.93M
  • ANAB ANAPTYSBIO INC · $35.03M
  • KALV KALVISTA PHARMACEUTICALS INC · $33.13M
  • EOLS EVOLUS INC · $28.31M
  • IMGN IMMUNOGEN INC · $23.80M
  • EQRX EQRX INC · $22.39M
  • AXSM AXSOME THERAPEUTICS INC. · $22.36M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest TANG CAPITAL MANAGEMENT LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-11-10 Buy Boundless Bio, Inc. 249 $2.40 SEC filing
2026-11-06 Buy Boundless Bio, Inc. 1,700 $2.40 SEC filing
2026-11-05 Buy Boundless Bio, Inc. 8,390 $2.40 SEC filing
2026-11-04 Buy Boundless Bio, Inc. 517 $2.40 SEC filing
2026-11-03 Buy Boundless Bio, Inc. 2,255 $2.40 SEC filing
2026-10-27 Buy Boundless Bio, Inc. 10,707 $2.40 SEC filing
2026-10-26 Buy Boundless Bio, Inc. 9,606 $2.38 SEC filing
2026-10-23 Buy Boundless Bio, Inc. 6,234 $2.38 SEC filing

All insider transactions →

Fund Profile

Tang Capital Management is an SEC-registered 13F filer. As of Q3 2026 it reported 45 US equity positions with a combined value of $2.17B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Portfolio Structure

  • 45 positions · $2.17B reported value (Q3 2026)
  • Top 10 holdings = 64.3% of reported value
  • Largest position: AUPH (AURINIA PHARMACEUTICALS INC) at 9.7%
  • Average position size: $48.31M

Sector Tilt

  • Health Care 89.7%
  • Information Technology 1.5%
  • (classified holdings cover 91% of value)

Quarterly Activity

  • Q3 2026: 5 new, 12 added, 1 reduced, 1 exited
  • 27 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 65.1%
Financials 1.9%
Materials 1.5%
Technology 0.5%
Other 29.7%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.14M $38.04M 5.37%
5.37%
New
2 1.14M $35.93M 5.07%
5.07%
New
3 1.95M $35.03M 4.94%
4.94%
New
4 3.44M $33.13M 4.67%
4.67%
New
5 3.10M $28.31M 4.00%
4.00%
New
6 1.50M $23.80M 3.36%
3.36%
New
7 10.09M $22.39M 3.16%
3.16%
New
8 320.00K $22.36M 3.16%
3.16%
New
9 405.60K $21.05M 2.97%
2.97%
New
10 1.61M $18.22M 2.57%
2.57%
New
11 30.00K $16.11M 2.27%
2.27%
New
12 300.00K $15.63M 2.21%
2.21%
New
13 300.00K $15.29M 2.16%
2.16%
New
14 85.00K $15.29M 2.16%
2.16%
New
15 4.28M $13.02M 1.84%
1.84%
New
16 1.80M $12.74M 1.80%
1.80%
New
17 397.60K $12.57M 1.77%
1.77%
New
18 170.00K $11.51M 1.62%
1.62%
New
19 1.80M $11.50M 1.62%
1.62%
New
20 3.60M $10.80M 1.52%
1.52%
New
21 600.00K $10.42M 1.47%
1.47%
New
22 1.00M $10.30M 1.45%
1.45%
New
23 669.12K $10.26M 1.45%
1.45%
New
24 200.00K $9.07M 1.28%
1.28%
New
25 271.20K $8.89M 1.25%
1.25%
New
26 24.00K $8.60M 1.21%
1.21%
New
27 2.82M $8.42M 1.19%
1.19%
New
28 6.45M $8.32M 1.17%
1.17%
New
29 591.64K $8.09M 1.14%
1.14%
New
30 492.10K $7.95M 1.12%
1.12%
New
31 76.70K $7.92M 1.12%
1.12%
New
32 180.00K $7.84M 1.11%
1.11%
New
33 891.51K $7.25M 1.02%
1.02%
New
34 2.75M $7.15M 1.01%
1.01%
New
35 1.10M $6.97M 0.98%
0.98%
New
36 3.78M $6.42M 0.91%
0.91%
New
37 935.80K $6.28M 0.89%
0.89%
New
38 750.00K $5.83M 0.82%
0.82%
New
39 621.14K $5.62M 0.79%
0.79%
New
40 300.00K $5.51M 0.78%
0.78%
New
41 3.51M $5.41M 0.76%
0.76%
New
42 5.86M $5.39M 0.76%
0.76%
New
43 2.02M $5.00M 0.71%
0.71%
New
44 1.36M $4.87M 0.69%
0.69%
New
45 300.00K $4.43M 0.62%
0.62%
New
46 166.20K $4.20M 0.59%
0.59%
New
47 100.00K $4.11M 0.58%
0.58%
New
48 5.17M $4.03M 0.57%
0.57%
New
49 3.50M $3.92M 0.55%
0.55%
New
50 210.00K $3.77M 0.53%
0.53%
New

FAQ

What did TANG CAPITAL MANAGEMENT LLC buy in 2023-Q3?

In its 2023-Q3 13F filing, TANG CAPITAL MANAGEMENT LLC reported 106 equity positions worth $708.68M in aggregate; its largest disclosed positions were TARS ($38.04M), MIRM ($35.93M), ANAB ($35.03M).

How large is TANG CAPITAL MANAGEMENT LLC's portfolio?

TANG CAPITAL MANAGEMENT LLC reported $708.68M of long equity holdings across 106 positions as of 2023-Q3. Top-10 holdings account for 39.3% of reported value.

What is TANG CAPITAL MANAGEMENT LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tang-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →